The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
We demonstrate label- and spectral-analysis-free nanolaser biosensor, whose emission is changed by the surface charge. In this study, we applied this to sensing CRMP2 protein, which is expected to become a biomarker of neuropsychiatric disorder.
Prostate cancer rates among the most common diagnosed cancer in men in the European Union and is the first in incidence and third in mortality among all cancer diseases. As with all types of cancer, the positive outcome of treatment depends on early diagnostics and treatment initiation. Currently, blood serum prostate specific antigen (PSA) level test is being widely used for prostate cancer detection,...
In a society, public health plays an important role in human life. There is no human being who is ideally healthy. Every family will have some ill health, sickness and a need exists for medication. In a locality a hospital is an essential establishment for the caretaking of the health of the people around. Every human being may have certain level of toxicity causing disturbance in normal function...
In this investigation, we present a novel label-free immunosensor platform based on inorganic barium strontium titanate (BST) thin film and interdigitated microelectrodes for clinical point-of-care application. The immunosensor is based on non-faradaic process, using DI water as electrolyte. As proof of concept, anti-human IgG, a common biomarker found and associated with many diseases was immobilized...
The potential for associating panels of biomarkers with disease states and the need to rapidly diagnose pathogenic threats requires the development of new biosensor technologies which can combine the multiplexing capabilities of traditional microarrays with the sensitivity of emerging nanosensors. In this paper we introduce our Nanoscale Optofluidic Sensors Arrays which combine the advantages of both...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.